Emergent BioSolutions Inc. (EBS)
NYSE: EBSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 7.08 +0.14%
EBS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $362.50M
- Forward P/E
- 6.76
- EPS (TTM)
- -$3.40
- Dividend yield
- None
- 52-week range
- 4.36 – 14.06
- Day range
- 6.86 – 7.35
- Volume / Avg
- 1.23M / 1.16M
- Beta
- —
- Shares outstanding
- 51.27M
- Next earnings
- Nov 4, 2026
52-week range
EBS stock today
On Oct 7, EBS ended the session at $7.07, adding $0.12 (1.73%), versus the S&P 500's 0.22% decline. At this level, EBS sits in the middle of its 52-week range of $4.36 to $14.06: 49.7% below the high and 62.2% above the low. Emergent BioSolutions has posted a net loss over the last twelve months (EPS of -$3.40), so its P/E ratio is not meaningful.
Emergent BioSolutions's next earnings report is expected on Nov 4, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Emergent BioSolutions
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2006
Earnings
Earnings history- Next report
- Nov 4, 2026
- EPS estimate
- $-0.45
Emergent BioSolutions peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ENTAEnanta Pharmaceuticals Inc. | 12.37 | +1.64% | $360.28M | vs EBS |
| ARCTArcturus Therapeutics Holdings Inc. | 12.77 | -1.81% | $362.82M | vs EBS |
| GALTGalectin Therapeutics Inc. | 3.62 | -3.72% | $365.08M | vs EBS |
| RLMDRelmada Therapeutics Inc. | 3.25 | -0.91% | $346.68M | vs EBS |
| IRDOpus Genetics Inc. | 4.41 | +0.68% | $366.89M | vs EBS |
| TTRXTurn Therapeutics Inc. | 12.10 | +3.95% | $367.45M | vs EBS |
| CYPHCypherpunk Technologies Inc. | 3.05 | -6.44% | $328.68M | vs EBS |
| BNTCBenitec Biopharma Inc. | 8.99 | -0.11% | $313.60M | vs EBS |
Indexes, lists and sector
Largest Health Care stocks
Emergent BioSolutions stock FAQ
What is Emergent BioSolutions's stock price today?
EBS last traded at $7.07 as of Oct 7, 4:00 PM EDT, up 1.73% on the day. Prices are delayed at least 15 minutes.
When is Emergent BioSolutions's next earnings date?
Emergent BioSolutions is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-0.45.
What is the EBS 52-week high?
The 52-week high for EBS is $14.06 and the 52-week low is $4.36. The stock is currently 49.7% below its high.